Busslinger, S. D., Mapanao, A. K., Kegler, K., Bernhardt, P., Flühmann, F., Fricke, J., . . . Müller, C. (2024). Comparison of the tolerability of 161Tb- and 177Lu-labeled somatostatin analogues in the preclinical setting. European Journal of Nuclear Medicine & Molecular Imaging, 51(13), 4049. https://doi.org/10.1007/s00259-024-06827-2
Chicago Style (17th ed.) CitationBusslinger, Sarah D., et al. "Comparison of the Tolerability of 161Tb- and 177Lu-labeled Somatostatin Analogues in the Preclinical Setting." European Journal of Nuclear Medicine & Molecular Imaging 51, no. 13 (2024): 4049. https://doi.org/10.1007/s00259-024-06827-2.
MLA (9th ed.) CitationBusslinger, Sarah D., et al. "Comparison of the Tolerability of 161Tb- and 177Lu-labeled Somatostatin Analogues in the Preclinical Setting." European Journal of Nuclear Medicine & Molecular Imaging, vol. 51, no. 13, 2024, p. 4049, https://doi.org/10.1007/s00259-024-06827-2.